Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, review timing and choice of first-line antiretroviral therapy in this unique program with a didactic video module and several case-based vignettes in which you are invited to help manage the patient.
Upon completion of this activity, participants should be able to:
Current Evidence on Integrase Inhibitors in First-line therapy: Should They Be Your First Choice?
Fall 2014 HIV Update
Sizing Up the Newest Integrase Inhibitor–Based Single-Tablet Regimen
To Switch or Not to Switch: Management of First-line Boosted PI Virologic Failure
Finding the Fit With Fixed-Dose Combination Antiretroviral Regimens
Clinical Care Options, LLC. All Rights Reserved.